Investing.com - Sabre Corpo (NASDAQ: SABR) reported first quarter EPS of $-0.020, $0.03 better than the analyst estimate of $-0.050. Revenue for the quarter came in at $783M versus the consensus estimate of $763.84M.
Guidance
Sabre Corpo sees Q2 2024 revenue of $750.000M versus the analyst consensus of $756.230M.
Sabre Corpo's stock price closed at $2.90. It is down -30.120% in the last 3 months and down -26.580% in the last 12 months.
Sabre Corpo saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Sabre Corpo's stock price’s past reactions to earnings here.
According to InvestingPro, Sabre Corpo's Financial Health score is "fair performance".
Check out Sabre Corpo's recent earnings performance, and Sabre Corpo's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar